Skip to Content

Allscripts Healthcare Solutions Inc MDRX

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


No-Moat Allscripts Reports Q4 Results In Line With Expectations; Expect to Maintain $11.40 FVE

Soo Romanoff Equity Analyst

Analyst Note

| Soo Romanoff |

No-moat Allscripts reported fourth-quarter and full-year results that exceeded consensus expectations but were largely in line with our estimates both on the top and bottom line. Improved mix and holistic cost-management efforts were key contributors in the quarter. For the full year, the company posted total revenue of $1.5 billion, declining about 15% from the prior year. We are maintaining our no-moat rating and do not expect to make significant changes to our fair value estimate of $11.40 per share.

Read Full Analysis

Company Profile

Business Description

Allscripts Healthcare Solutions provides information technology and offerings to acute and ambulatory providers as well as hospital services. The company supports electric medical records, private cloud hosting, and other clinical services that support patient engagement and better outcomes. Additionally, the company offers administrative tools and services to improve operations, such as practice management, revenue cycle management, and clinical care coordination. Allscripts was founded in 1986 and is headquartered in Chicago.

222 Merchandise Mart Plaza, Suite 2024
Chicago, IL, 60654
T +1 800 334-8534
Sector Healthcare
Industry Health Information Services
Most Recent Earnings Dec 31, 2020
Fiscal Year End Dec 31, 2021
Stock Type Distressed
Employees 8,400